EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Use of Hexokinase 2-Displacing Peptides as an Anti-Neoplastic Approach for Malignant Peripheral Nerve Sheath Tumors

Francesco Ciscato iD, Ionica Masgras, Alessandro Gori iD, Marco Fantuz iD, Greta Bergamaschi iD, Denis Komarov, Martina La Spina, Shiva Ghasemi-Firouzabadi, Marco Pizzi, Angelo Paolo Dei Tos, Federica Chiara iD, Alessandro Carrer iD und 1 weitere

Cells · 2024

DOI: 10.3390/cells13131162 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2024. Verfasst von Francesco Ciscato und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, University of Padova, 35131 Padova, Italy. Hauptthemen laut MEDLINE: Hexokinase, Peptides. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Association for Cancer Research, Children’s Tumor Foundation, Italian Ministry of University and Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Malignant Peripheral Nerve Sheath Tumors (MPNSTs) are aggressive sarcomas that can arise both sporadically and in patients with the genetic syndrome Neurofibromatosis type 1 (NF1). Prognosis is dismal, as large dimensions, risk of relapse, and anatomical localization make surgery poorly effective, and no therapy is known. Hence, the identification of MPNST molecular features that could be hit in an efficient and selective way is mandatory to envision treatment options. Here, we find that MPNSTs express high levels of the glycolytic enzyme Hexokinase 2 (HK2), which is known to shield cancer cells from noxious stimuli when it localizes at MAMs (mitochondria-associated membranes), contact sites between mitochondria and endoplasmic reticulum. A HK2-targeting peptide that dislodges HK2 from MAMs rapidly induces a massive death of MPNST cells. After identifying different matrix metalloproteases (MMPs) expressed in the MPNST microenvironment, we have designed HK2-targeting peptide variants that harbor cleavage sites for these MMPs, making such peptides activatable in the proximity of cancer cells. We find that the peptide carrying the MMP2/9 cleavage site is the most effective, both in inhibiting the in vitro tumorigenicity of MPNST cells and in hampering their growth in mice. Our data indicate that detaching HK2 from MAMs could pave the way for a novel anti-MPNST therapeutic strategy, which could be flexibly adapted to the protease expression features of the tumor microenvironment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HexokinasePeptidesHumansAnimalsCell Line, TumorMiceNerve Sheath NeoplasmsAntineoplastic AgentsXenograft Model Antitumor AssaysCell ProliferationMatrix Metalloproteinase 2MitochondriaTumor Microenvironment

Stichwörter der Autor:innen

Neurofibromatosis type 1hexokinase 2hexokinase 2 targeting peptidesmalignant peripheral nerve sheath tumors

Substanzen

HexokinasePeptidesHK2 protein, humanAntineoplastic AgentsMatrix Metalloproteinase 2

Autor:innen und Institutionen

  • Department of Biomedical Sciences, University of Padova, 35131 Padova, Italy.
  • Institute of Neuroscience, National Research Council (CNR), 35131 Padova, Italy.
  • SCITEC Institute of Chemical Science and Technology "Giulio Natta", National Research Council (CNR), 20133 Milano, Italy.
  • Veneto Institute for Molecular Medicine (VIMM), 35129 Padova, Italy.
  • Department of Biology, University of Padova, 35131 Padova, Italy.
  • General Pathology and Cytopathology Unit, Department of Medicine (DMED), University of Padova, 35128 Padova, Italy.

ORCID-Profile: Francesco Ciscato, Alessandro Gori, Marco Fantuz, Greta Bergamaschi, Federica Chiara, Alessandro Carrer, Andrea Rasola

Förderung

  • Italian Association for Cancer Research
  • Children’s Tumor Foundation
  • Italian Ministry of University and Research
  • Young Investigator Award Grant from Children’s Tumor Foundation

Zitieren

APA

Ciscato, F., Masgras, I., Gori, A., Fantuz, M., Bergamaschi, G., Komarov, D., La Spina, M., Ghasemi-Firouzabadi, S., Pizzi, M., Dei Tos, A. P., Chiara, F., Carrer, A., & Rasola, A. (2024). The Use of Hexokinase 2-Displacing Peptides as an Anti-Neoplastic Approach for Malignant Peripheral Nerve Sheath Tumors. Cells. https://doi.org/10.3390/cells13131162

Vancouver

Ciscato F, Masgras I, Gori A, Fantuz M, Bergamaschi G, Komarov D, et al. The Use of Hexokinase 2-Displacing Peptides as an Anti-Neoplastic Approach for Malignant Peripheral Nerve Sheath Tumors. Cells. 2024. doi:10.3390/cells13131162

BibTeX
@article{Ciscato2024,
  author = {Ciscato, Francesco and Masgras, Ionica and Gori, Alessandro and Fantuz, Marco and Bergamaschi, Greta and Komarov, Denis and La Spina, Martina and Ghasemi-Firouzabadi, Shiva and Pizzi, Marco and Dei Tos, Angelo Paolo and Chiara, Federica and Carrer, Alessandro and Rasola, Andrea},
  title = {The Use of Hexokinase 2-Displacing Peptides as an Anti-Neoplastic Approach for Malignant Peripheral Nerve Sheath Tumors},
  journal = {Cells},
  year = {2024},
  doi = {10.3390/cells13131162}
}
Kostenlos starten →